Triofan Pastilles pectorales

7680621210021 CH-62121 Pastillen
Triofan Pastilles pectorales
Triofan Pastilles pectorales
Triofan Pastilles pectorales
1 / 3
google

Article details

Package size
40
Selling units
40
Measure
Tablette(n)
Galenic form
Pastillen
Galenic group
Lutschtabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/07/2023
Patient information leaflet
Français
04/07/2023
Patient information leaflet
Italien
04/07/2023

Detailed composition

Substance Quantity Type Category
(N/A)
3.1 MG Substance Wirkstoff (Principe actif)
(N/A)
1.4 MG Substance Wirkstoff (Principe actif)
(N/A)
3.9 MG Substance Wirkstoff (Principe actif)
(N/A)
1.4 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
60.0 MG Substance Wirkstoff (Principe actif)
(N/A)
129.6 MG Substance Wirkstoff (Principe actif)
(N/A)
716.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Verfora SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
62121
Drug name
Triofan Pastilles pectorales
Galenic form
LUTT
ATC Code
R05FB02
Authorization status
Z
Authorization category
Category C
Dispensing category
E
First authorization
13/04/2011
Authorization expiration date
31/12/9999
IT Number
03.02.0.
Domain
Human medicine
Field of application
Bei Erkältungshusten

Package details

Description (FR)
TRIOFAN Pastilles pectorales bte 40 pce
Description (DE)
TRIOFAN Bronchialpastillen Ds 40 Stk
Market launch
13/04/2011
Narcotic (BTM)
No

Other package sizes (1)

DEMOPECTOL pastilles pectorales bte 40 pce
None None
GTIN: 7680621210014
Not in V1